TREM1 and peripheral arterial disease: These data support a proposed hypothesis that activated platelets in PAD patients lead to stimulation of PMN and monocytes by the interaction of TREM-ligand with TREM-1, which causes an increase in ROS production and greater platelet activation in a positive feedback loop [9].